# CEQUA for Sjogren's Syndrome Dry Eye

> **NCT04835623** · PHASE4 · COMPLETED · sponsor: **Center for Ophthalmic and Vision Research, LLC** · enrollment: 50 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Syndromes
- Sjogren's Syndrome

## Interventions

- **DRUG:** Cyclosporine 0.09% Ophthalmic Solution

## Key facts

- **NCT ID:** NCT04835623
- **Lead sponsor:** Center for Ophthalmic and Vision Research, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-21
- **Primary completion:** 2024-03-21
- **Final completion:** 2024-03-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835623, "CEQUA for Sjogren's Syndrome Dry Eye". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04835623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*